The 21st Century Cares Act was passed with an overwhelming majority on July 10th, 2015. This bill would increase the funding for both the NIH and FDA and instate a new framework for evaluating patience’s experience with drugs risks and benefits. Not only will the bill...
A recent study by Frost & Sullivan shows that the clinical research market for contract research organizations (CROs) in Latin America are projected to grow at a rate of 7.1% for the next four years, as it predicts that the larger CROs will take the greatest...
23andMe, a DNA analysis service company who provides information and tools to individuals to learn more about their DNA has announced its plan to invent its own drugs using customer data. This drastic move will allow 23andMe to capitalize on the economic value its...
FierceBiotechIT writer Ryan McBride reports that GlaxoSmithKline (GSK) launched a website that will allow authorized researchers the ability to use clinical study data on certain drugs from the London based pharma company. This launches GSK to the forefront of...
One of the greatest challenges of clinical research is patient recruitment and retention according to Tufts Center for the Study of Drug Development (CSDD). To help clinical research professionals improve clinical trial management, Tufts CSDD analyzed more than 150...
